BALTIMORE, April 4, 2008 /PRNewswire/ -- Newly published data by Dr. J.
Barthelow Classen in The Open Endocrinology Journal shows a 50% reduction
of type 2 diabetes occurred in Japanese children following the
discontinuation of a single vaccine, a vaccine to prevent tuberculosis.
This decline occurred at a time when there is a global epidemic of type 2
diabetes and metabolic syndrome, which includes obesity, altered blood
cholesterol levels, high blood pressure, and increased blood glucose
resulting from insulin resistance.
Classen proposes a new explanation for the epidemic of both insulin
dependent diabetes (type 1 diabetes), which has previously been shown to be
caused by vaccines and non insulin dependent diabetes (type 2 diabetes).
Upon receipt of vaccines or other strong immune stimulants some individuals
develop a hyperactive immune system leading to autoimmune destruction of
insulin secreting cells. Other individuals produce increased cortisol, an
immune suppressing hormone, to suppress the vaccine induced inflammation.
The increased cortisol leads to type 2 diabetes and metabolic syndrome.
Japanese children have increased cortisol secretion following immunization
compared to White children and this explains why Japanese have a relative
high rate of type 2 diabetes but low rate of insulin dependent diabetes
compared to Whites. The lower cortisol response attributed to type 1
diabetes and the higher cortisol response attributed to type 2 diabetes
explains why type 1 diabetics are generally leaner than type 2 diabetics
since elevated cortisol causes weight gain.
"The current data shows that vaccines are much more dangerous than the
public is lead to believe and adequate testing has never been performed
even in healthy subjects to indicate that there is an overall improvement
in health from immunization. The current practice of vaccinating diabetics
as well as their close family members is a very risky practice," says Dr.
J. Barthelow Classen.
Classen's research has become widely accepted. To view the published
papers and to find out the latest information on the effects of vaccines on
autoimmune diseases including insulin dependent diabetes visit the Vaccine
Safety Web site http://www.vaccines.net/newpage11.htm
Classen Immunotherapies, Inc.
6517 Montrose Avenue Baltimore, MD 21212 U.S.A.
Tel: (410) 377-8526 Classen@vaccines.net
SOURCE Classen Immunotherapies, Inc.